title: Prevalence of depression and its treatment in an elderly population: the Cache County study.
abstract: BACKGROUND
  Previous estimates of the prevalence of geriatric depression have varied. There are few large population-based studies; most of these focused on individuals younger than 80 years. No US studies have been published since the advent of the newer antidepressant agents.
  
  
  METHODS
  In 1995 through 1996, as part of a large population study, we examined the current and lifetime prevalence of depressive disorders in 4,559 nondemented individuals aged 65 to 100 years. This sample represented 90% of the elderly population of Cache County, Utah. Using a modified version of the Diagnostic Interview Schedule, we ascertained past and present DSM-IV major depression, dysthymia, and subclinical depressive disorders. Medication use was determined through a structured interview and a "medicine chest inventory."
  
  
  RESULTS
  Point prevalence of major depression was estimated at 4.4% in women and 2.7% in men (P= .003). Other depressive syndromes were surprisingly uncommon (combined point prevalence, 1.6%). Among subjects with current major depression, 35.7% were taking an antidepressant (mostly selective serotonin reuptake inhibitors) and 27.4% a sedative/hypnotic. The current prevalence of major depression did not change appreciably with age. Estimated lifetime prevalence of major depression was 20.4% in women and 9.6% in men (P<.001), decreasing with age.
  
  
  CONCLUSIONS
  These estimates for prevalence of major depression are higher than those reported previously in North American studies. Treatment with antidepressants was more common than reported previously, but was still lacking in most individuals with major depression. The prevalence of subsyndromal depressive symptoms was low, possibly because of unusual characteristics of the population.
authors.affiliation: Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA.
authors.forename: D C
authors.initials: DC
authors.lastname: Steffens
authors.forename: I
authors.initials: I
authors.lastname: Skoog
authors.forename: M C
authors.initials: MC
authors.lastname: Norton
authors.forename: A D
authors.initials: AD
authors.lastname: Hart
authors.forename: J T
authors.initials: JT
authors.lastname: Tschanz
authors.forename: B L
authors.initials: BL
authors.lastname: Plassman
authors.forename: B W
authors.initials: BW
authors.lastname: Wyse
authors.forename: K A
authors.initials: KA
authors.lastname: Welsh-Bohmer
authors.forename: J C
authors.initials: JC
authors.lastname: Breitner
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000928:Antidepressive Agents / Q000627:therapeutic use; D001601:Bereavement; D003866:Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D004363:Drug Utilization; D005260:Female; D006306:Health Surveys; D006801:Humans; D008297:Male; D010818:Practice Patterns, Physicians'; D015995:Prevalence; D011569:Psychiatric Status Rating Scales / Q000706:statistics & numerical data; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D012737:Sex Factors; D011795:Surveys and Questionnaires; D014589:Utah / Q000453:epidemiology
chemical_list: D000928:Antidepressive Agents; D017367:Selective Serotonin Reuptake Inhibitors